University of California San Francisco
Give to UCSF
Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.
UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.
Discoveries result from a mix of smarts, creativity, grit, collaboration, serendipity and time. But when scientists must constantly apply for funding, that last factor can be hard to come by. The Arc
A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Using both cannabis and tobacco increases depression and anxiety risk, highlighting the need for integrated support, says UC San Francisco study.
A UCSF telecare program improves outcomes for patients with dementia and lightens the load for unpaid caregivers while cutting Medicare costs.
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
Babies who experience malnutrition may also experience worse cognitive development and have higher chances of death.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.
UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.
